955 related articles for article (PubMed ID: 23600759)
1. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
3. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
4. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
Barnham KJ; Bush AI
Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
[TBL] [Abstract][Full Text] [Related]
5. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
6. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
7. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
8. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
9. Yeast models for amyloid disease.
Panaretou B; Jones GW
Essays Biochem; 2014; 56():85-97. PubMed ID: 25131588
[TBL] [Abstract][Full Text] [Related]
10. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
11. Developing therapeutics for the diseases of protein misfolding.
May BC; Govaerts C; Cohen FE
Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
[TBL] [Abstract][Full Text] [Related]
12. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
13. Involvement of molecular chaperone in protein-misfolding brain diseases.
Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
15. [Neurodegenerative amyloidoses: the yeast model].
Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
[TBL] [Abstract][Full Text] [Related]
16. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
17. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
19. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
Saxena S; Caroni P
Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
[TBL] [Abstract][Full Text] [Related]
20. Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity.
Kryndushkin D; Shewmaker F
Prion; 2011; 5(4):250-7. PubMed ID: 22052354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
